Oncology Department, Affiliated Xinxiang Central Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
J Cell Biochem. 2020 Feb;121(2):1690-1702. doi: 10.1002/jcb.29404. Epub 2019 Oct 3.
Long noncoding RNA, RNA component of mitochondrial RNA processing endoribonuclease (RMRP) plays an important role in cancer development and is closely correlated with prognosis in cancer patients. However, whether RMRP affects prognosis in patients with hepatocellular carcinoma (HCC) remains unclear. The aim of the present study was to investigate the expression level of RMRP in HCC and its correlation with prognosis in patients with HCC and explain the effects and associated mechanisms by conducting an in vitro study. The high expression level of RMRP was correlated with poor prognosis in patients with HCC. Using in vitro analysis, RMRP knockdown suppressed HCC cell proliferation, invasion, and migration (P < .05). miRNA-206 overexpression had similar effects in HCC cell lines (Bel-7402 and Huh-7). Using Western blot analysis and cellular immunofluorescence detection, RMRP downregulation significantly suppressed TACR1/Erk1/2 pathway, while miRNA-206 was significantly upregulated (P < .05). RMRP downregulation inhibits HCC-related biological activities by the regulation of miRNA-206/TACR1.
长链非编码 RNA、线粒体 RNA 加工内切核糖核酸酶(RMRP)的 RNA 成分在癌症发展中发挥重要作用,并且与癌症患者的预后密切相关。然而,RMRP 是否影响肝癌(HCC)患者的预后尚不清楚。本研究旨在探讨 RMRP 在 HCC 中的表达水平及其与 HCC 患者预后的相关性,并通过体外研究解释其作用及相关机制。RMRP 的高表达水平与 HCC 患者的不良预后相关。通过体外分析,RMRP 敲低抑制 HCC 细胞的增殖、侵袭和迁移(P<.05)。miRNA-206 过表达在 HCC 细胞系(Bel-7402 和 Huh-7)中也具有类似的作用。通过 Western blot 分析和细胞免疫荧光检测,RMRP 下调显著抑制 TACR1/Erk1/2 通路,而 miRNA-206 则显著上调(P<.05)。RMRP 通过调节 miRNA-206/TACR1 抑制 HCC 相关的生物学活性。